common.study.topics.clinical

Cocaine Use Disorder and Cortical Dopamine

common.study.values.description

“Cocaine Use Disorder and Cortical Dopamine”

The goal of this study is to use [C-11]FLB 457 and amphetamine (oral, 0.5 mg/kg) to measure cortical dopamine transmission in cocaine dependent individuals and healthy controls

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - d-amphetamine

oral d- amphetamine 0.5 mg/kg is used to stimulate dopamine release in the brain

Radiation - [C-11]FLB 457

PET radiotracer

participant.views.study.view.additional

participant.views.study.view.scientific-title

Imaging of Cortical Dopamine Transmission in Cocaine Dependence

common.study.values.clinical-trial-id

NCT03349606

participant.views.study.view.id

YaOrGe